XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Mar. 31, 2017
Mar. 31, 2016
CURRENT ASSETS      
Cash $ 327,206 $ 1,559,701 $ 2,123,737
Accounts receivable   0 199,471
Prepaid expenses and other current assets 38,450 37,551 53,294
TOTAL CURRENT ASSETS 365,656 1,597,252 2,376,502
Property and equipment, net 45,893 29,223 36,038
Patents, net 82,705 84,996 94,161
Deposits 14,897 14,897 22,415
TOTAL ASSETS 509,151 1,726,368 2,529,116
CURRENT LIABILITIES      
Accounts payable 277,094 484,423 244,804
Due to related parties 48,366 57,866 145,112
Other current liabilities 82,845 69,467 136,695
TOTAL CURRENT LIABILITIES 408,305 611,756 526,611
Convertible notes payable, net 1,050,911 519,200 500,139
TOTAL LIABILITIES 1,459,216 1,130,956 1,026,750
COMMITMENTS AND CONTINGENCIES (Note 12)
STOCKHOLDERS' EQUITY      
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2017 and 2016; 8,797,086 and 7,622,393 issued and outstanding at March 31, 2017 and 2016, respectively 8,869 8,796 7,621
Additional paid-in capital 94,745,740 94,445,739 88,047,142
Accumulated deficit (95,619,939) (93,778,156) (86,502,043)
TOTAL AETHLON MEDICAL, INC STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS (865,330) 676,379 1,552,720
NONCONTROLLING INTERESTS (84,735) (80,967) (50,354)
TOTAL STOCKHOLDERS' EQUITY (950,065) 595,412 1,502,366
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 509,151 $ 1,726,368 $ 2,529,116